(2E,4E)-hexa-2,4-dienoic acid increases expression ISO RGD:1315620 6480464 Sorbic Acid results in increased expression of RAD51AP1 protein CTD PMID:20025956 1,2-dimethylhydrazine increases expression ISO RGD:1315620 6480464 1, 2-Dimethylhydrazine results in increased expression of RAD51AP1 mRNA CTD PMID:22206623 1,4-dioxane increases expression ISO RGD:1315620 6480464 1, 4-dioxane results in increased expression of RAD51AP1 protein CTD PMID:20025956 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RAD51AP1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:1315620 6480464 Ethinyl Estradiol affects the expression of RAD51AP1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1315620 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAD51AP1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1353541 6480464 Estradiol results in increased expression of RAD51AP1 mRNA CTD PMID:16474171 more ... 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1315620 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1315620 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1315620 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAD51AP1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1315620 6480464 Tetrachlorodibenzodioxin affects the expression of RAD51AP1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1353541 6480464 Tetrachlorodibenzodioxin results in decreased expression of RAD51AP1 mRNA CTD PMID:21632981 , PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1315620 6480464 Tetrachlorodibenzodioxin results in increased expression of RAD51AP1 mRNA CTD PMID:17942748 2,4-diaminotoluene increases expression ISO RGD:1315620 6480464 2, 4-diaminotoluene results in increased expression of RAD51AP1 mRNA CTD PMID:20713471 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:1315620 6480464 Butylated Hydroxytoluene results in increased expression of RAD51AP1 mRNA CTD PMID:19000923 2-butoxyethanol increases expression ISO RGD:1315620 6480464 n-butoxyethanol results in increased expression of RAD51AP1 mRNA CTD PMID:19812364 3-methylcholanthrene increases expression ISO RGD:1315620 6480464 Methylcholanthrene results in increased expression of RAD51AP1 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide increases expression ISO RGD:1315620 6480464 Fenretinide results in increased expression of RAD51AP1 mRNA CTD PMID:28973697 7,12-dimethyltetraphene increases expression ISO RGD:1315620 6480464 9 more ... CTD PMID:20025956 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:1353541 6480464 apocarotenal results in increased expression of RAD51AP1 mRNA CTD PMID:17034753 acetamide increases expression EXP 6480464 acetamide results in increased expression of RAD51AP1 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1315620 6480464 Acrylamide results in increased expression of RAD51AP1 protein CTD PMID:20025956 acrylamide decreases expression ISO RGD:1353541 6480464 Acrylamide results in decreased expression of RAD51AP1 mRNA CTD PMID:32763439 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of RAD51AP1 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1353541 6480464 Aflatoxin B1 affects the expression of RAD51AP1 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1315620 6480464 Aflatoxin B1 results in decreased expression of RAD51AP1 mRNA CTD PMID:19770486 aflatoxin M1 decreases expression ISO RGD:1353541 6480464 Aflatoxin M1 results in decreased expression of RAD51AP1 mRNA CTD PMID:30928695 all-trans-retinoic acid increases expression ISO RGD:1315620 6480464 Tretinoin results in increased expression of RAD51AP1 protein CTD PMID:20025956 all-trans-retinoic acid decreases expression ISO RGD:1353541 6480464 Tretinoin results in decreased expression of RAD51AP1 mRNA CTD PMID:33167477 anthracene-1,8,9-triol increases expression ISO RGD:1315620 6480464 Anthralin results in increased expression of RAD51AP1 protein CTD PMID:20025956 azathioprine decreases expression ISO RGD:1353541 6480464 Azathioprine results in decreased expression of RAD51AP1 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1315620 6480464 Benzo(a)pyrene results in decreased expression of RAD51AP1 mRNA CTD PMID:19770486 , PMID:21569818 benzo[a]pyrene increases expression ISO RGD:1353541 6480464 Benzo(a)pyrene results in increased expression of RAD51AP1 mRNA CTD PMID:32234424 benzo[a]pyrene increases expression ISO RGD:1315620 6480464 Benzo(a)pyrene results in increased expression of RAD51AP1 mRNA CTD PMID:20713471 , PMID:22610609 benzo[a]pyrene decreases expression ISO RGD:1353541 6480464 Benzo(a)pyrene results in decreased expression of RAD51AP1 mRNA CTD PMID:20064835 , PMID:21802500 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1353541 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1315620 6480464 benzo(b)fluoranthene results in increased expression of RAD51AP1 mRNA CTD PMID:26377693 beta-carotene decreases expression ISO RGD:1353541 6480464 beta Carotene results in decreased expression of RAD51AP1 mRNA CTD PMID:17034753 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1353541 6480464 Mustard Gas results in decreased expression of RAD51AP1 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:1353541 6480464 bisphenol A results in increased expression of RAD51AP1 mRNA CTD PMID:16474171 bisphenol A affects expression ISO RGD:1353541 6480464 bisphenol A affects the expression of RAD51AP1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1353541 6480464 bisphenol A results in decreased expression of RAD51AP1 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of RAD51AP1 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RAD51AP1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1315620 6480464 bisphenol A results in decreased expression of RAD51AP1 mRNA CTD PMID:26063408 bleomycin A2 multiple interactions ISO RGD:1315620 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of RAD51AP1 mRNA], lenabasum inhibits the reaction [Bleomycin results in decreased expression of RAD51AP1 mRNA] CTD PMID:30825431 bleomycin A2 decreases expression ISO RGD:1315620 6480464 Bleomycin results in decreased expression of RAD51AP1 mRNA CTD PMID:30825431 buta-1,3-diene increases expression ISO RGD:1315620 6480464 1, 3-butadiene results in increased expression of RAD51AP1 mRNA CTD PMID:29038090 butylated hydroxyanisole increases expression ISO RGD:1315620 6480464 Butylated Hydroxyanisole results in increased expression of RAD51AP1 mRNA CTD PMID:19000923 cadmium dichloride increases expression ISO RGD:1353541 6480464 Cadmium Chloride results in increased expression of RAD51AP1 mRNA CTD PMID:26472689 caffeine increases expression ISO RGD:1315620 6480464 Caffeine results in increased expression of RAD51AP1 protein CTD PMID:20025956 caffeine affects phosphorylation ISO RGD:1353541 6480464 Caffeine affects the phosphorylation of RAD51AP1 protein CTD PMID:35688186 calcitriol multiple interactions ISO RGD:1353541 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RAD51AP1 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1353541 6480464 Calcitriol results in decreased expression of RAD51AP1 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO RGD:1315620 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of RAD51AP1 mRNA] CTD PMID:30825431 carbon nanotube increases expression ISO RGD:1315620 6480464 Nanotubes more ... CTD PMID:25554681 choline multiple interactions ISO RGD:1315620 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RAD51AP1 mRNA CTD PMID:20938992 cisplatin decreases phosphorylation ISO RGD:1315620 6480464 Cisplatin results in decreased phosphorylation of RAD51AP1 protein CTD PMID:22006019 cisplatin increases expression ISO RGD:1353541 6480464 Cisplatin results in increased expression of RAD51AP1 mRNA CTD PMID:27594783 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of RAD51AP1 mRNA CTD PMID:24386269 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of RAD51AP1 mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:1353541 6480464 [NSC 689534 binds to Copper] which results in decreased expression of RAD51AP1 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of RAD51AP1 mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:1353541 6480464 [NSC 689534 binds to Copper] which results in decreased expression of RAD51AP1 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1353541 6480464 Copper Sulfate results in decreased expression of RAD51AP1 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1353541 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1353541 6480464 Coumestrol results in increased expression of RAD51AP1 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1353541 6480464 Cyclosporine results in decreased expression of RAD51AP1 mRNA CTD PMID:20106945 more ... dibutyl phthalate decreases expression ISO RGD:1315620 6480464 Dibutyl Phthalate results in decreased expression of RAD51AP1 mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos decreases expression ISO RGD:1353541 6480464 dicrotophos results in decreased expression of RAD51AP1 mRNA CTD PMID:28302478 dioxygen decreases expression ISO RGD:1353541 6480464 Oxygen deficiency results in decreased expression of RAD51AP1 mRNA CTD PMID:26516004 doxorubicin decreases expression ISO RGD:1353541 6480464 Doxorubicin results in decreased expression of RAD51AP1 mRNA CTD PMID:30031762 Enterolactone multiple interactions ISO RGD:1353541 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51AP1 mRNA CTD PMID:19167446 ethyl methanesulfonate increases expression ISO RGD:1353541 6480464 Ethyl Methanesulfonate results in increased expression of RAD51AP1 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:1315620 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RAD51AP1 mRNA CTD PMID:20938992 furan increases expression EXP 6480464 furan results in increased expression of RAD51AP1 mRNA CTD PMID:25539665 genistein increases expression ISO RGD:1353541 6480464 Genistein results in increased expression of RAD51AP1 mRNA CTD PMID:16474171 imiquimod decreases expression ISO RGD:1315620 6480464 imiquimod results in decreased expression of RAD51AP1 mRNA CTD PMID:21878529 iron dichloride increases expression ISO RGD:1315620 6480464 ferrous chloride results in increased expression of RAD51AP1 protein CTD PMID:20025956 iron trichloride increases expression ISO RGD:1315620 6480464 ferric chloride results in increased expression of RAD51AP1 protein CTD PMID:20025956 L-methionine multiple interactions ISO RGD:1315620 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RAD51AP1 mRNA CTD PMID:20938992 lucanthone decreases expression ISO RGD:1353541 6480464 Lucanthone results in decreased expression of RAD51AP1 mRNA CTD PMID:21148553 MeIQx increases expression ISO RGD:1353541 6480464 2-amino-3 more ... CTD PMID:20816883 methamphetamine decreases expression ISO RGD:1353541 6480464 Methamphetamine results in decreased expression of RAD51AP1 mRNA CTD PMID:25290377 methyl methanesulfonate increases expression ISO RGD:1353541 6480464 Methyl Methanesulfonate results in increased expression of RAD51AP1 mRNA CTD PMID:23649840 Mezerein increases expression ISO RGD:1315620 6480464 mezerein results in increased expression of RAD51AP1 mRNA CTD PMID:19000923 N-nitrosodiethylamine increases expression ISO RGD:1315620 6480464 Diethylnitrosamine results in increased expression of RAD51AP1 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1315620 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of RAD51AP1 mRNA] CTD PMID:17854601 N-Nitrosopyrrolidine decreases expression ISO RGD:1353541 6480464 N-Nitrosopyrrolidine results in decreased expression of RAD51AP1 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1353541 6480464 Nickel results in increased expression of RAD51AP1 mRNA CTD PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RAD51AP1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of RAD51AP1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1315620 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RAD51AP1 mRNA more ... CTD PMID:25658374 , PMID:34911549 palbociclib decreases expression ISO RGD:1353541 6480464 palbociclib results in decreased expression of RAD51AP1 mRNA CTD PMID:22869556 palytoxin increases expression ISO RGD:1315620 6480464 palytoxin results in increased expression of RAD51AP1 protein CTD PMID:20025956 paracetamol increases expression ISO RGD:1315620 6480464 Acetaminophen results in increased expression of RAD51AP1 protein CTD PMID:20025956 paracetamol decreases expression ISO RGD:1353541 6480464 Acetaminophen results in decreased expression of RAD51AP1 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:1353541 6480464 Acetaminophen results in increased expression of RAD51AP1 mRNA CTD PMID:22230336 PCB138 multiple interactions ISO RGD:1315620 6480464 [2 more ... CTD PMID:25510870 phenacetin increases expression ISO RGD:1315620 6480464 Phenacetin results in increased expression of RAD51AP1 mRNA CTD PMID:19000923 phenobarbital increases expression ISO RGD:1315620 6480464 Phenobarbital results in increased expression of RAD51AP1 mRNA CTD PMID:23091169 phorbol 13-acetate 12-myristate increases expression ISO RGD:1353541 6480464 Tetradecanoylphorbol Acetate results in increased expression of RAD51AP1 mRNA CTD PMID:19031421 phorbol 13-acetate 12-myristate increases expression ISO RGD:1315620 6480464 Tetradecanoylphorbol Acetate results in increased expression of RAD51AP1 mRNA CTD PMID:19000923 picoxystrobin increases expression ISO RGD:1353541 6480464 picoxystrobin results in increased expression of RAD51AP1 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1353541 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RAD51AP1 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:1353541 6480464 Piroxicam results in decreased expression of RAD51AP1 mRNA CTD PMID:21858171 progesterone increases expression ISO RGD:1315620 6480464 Progesterone results in increased expression of RAD51AP1 mRNA CTD PMID:19000923 propanal decreases expression ISO RGD:1353541 6480464 propionaldehyde results in decreased expression of RAD51AP1 mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:1353541 6480464 Quercetin results in increased expression of RAD51AP1 mRNA CTD PMID:21632981 resveratrol decreases expression ISO RGD:1353541 6480464 resveratrol results in decreased expression of RAD51AP1 mRNA CTD PMID:15767336 resveratrol multiple interactions ISO RGD:1353541 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of RAD51AP1 mRNA CTD PMID:19167446 rotenone increases expression ISO RGD:1353541 6480464 Rotenone results in increased expression of RAD51AP1 mRNA CTD PMID:18191903 silicon dioxide decreases expression ISO RGD:1353541 6480464 Silicon Dioxide analog results in decreased expression of RAD51AP1 mRNA CTD PMID:23806026 silicon dioxide increases expression ISO RGD:1315620 6480464 Silicon Dioxide results in increased expression of RAD51AP1 mRNA CTD PMID:29341224 sodium arsenite affects methylation ISO RGD:1353541 6480464 sodium arsenite affects the methylation of RAD51AP1 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:1353541 6480464 sodium arsenite results in increased expression of RAD51AP1 mRNA CTD PMID:29301061 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of RAD51AP1 mRNA CTD PMID:22110744 sodium nitrite increases expression ISO RGD:1315620 6480464 Sodium Nitrite results in increased expression of RAD51AP1 protein CTD PMID:20025956 sulfadimethoxine increases expression ISO RGD:1315620 6480464 Sulfadimethoxine results in increased expression of RAD51AP1 mRNA CTD PMID:19000923 sunitinib decreases expression ISO RGD:1353541 6480464 Sunitinib results in decreased expression of RAD51AP1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1315620 6480464 Tamoxifen affects the expression of RAD51AP1 mRNA CTD PMID:17555576 tebufenpyrad increases expression ISO RGD:1353541 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of RAD51AP1 mRNA CTD PMID:33512557 testosterone decreases expression ISO RGD:1353541 6480464 Testosterone results in decreased expression of RAD51AP1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1353541 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RAD51AP1 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1315620 6480464 Carbon Tetrachloride affects the expression of RAD51AP1 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1315620 6480464 Carbon Tetrachloride results in increased expression of RAD51AP1 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RAD51AP1 mRNA CTD PMID:23411599 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of RAD51AP1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RAD51AP1 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1315620 6480464 Trichloroethylene results in increased expression of RAD51AP1 mRNA CTD PMID:25549359 triclosan decreases expression ISO RGD:1353541 6480464 Triclosan results in decreased expression of RAD51AP1 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1315620 6480464 trimellitic anhydride results in increased expression of RAD51AP1 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1353541 6480464 troglitazone results in decreased expression of RAD51AP1 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:1315620 6480464 trovafloxacin results in decreased expression of RAD51AP1 mRNA CTD PMID:35537566 urethane decreases expression ISO RGD:1353541 6480464 Urethane results in decreased expression of RAD51AP1 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1353541 6480464 Valproic Acid results in decreased expression of RAD51AP1 mRNA CTD PMID:28001369 zinc dichloride increases expression ISO RGD:1315620 6480464 zinc chloride results in increased expression of RAD51AP1 mRNA CTD PMID:19000923